Melatonin derivatives and combinations with antiestrogen compoun

Details Melatonin derivatives and combinations with antiestrogen compoun Melatonin derivatives and combinations with antiestrogen compoun

1991-11-21

1993-03-23

Nutter, Nathan M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514415, 514419, 514428, 514514, 514748, 514771, A01N 4338, A01N 4342, A61K 3144, A61K 31405

Patent

active

051964350

ABSTRACT:
Derivatives of melatonin and the pharmaceutically acceptable salts thereof are useful for therapeutically treating hormonally dependent mammalian breast carcinoma. Combination treatments of melatonin derivatives and an antiestrogen compound are especially useful.

REFERENCES:
patent: 4133814 (1979-01-01), Jones et al.
patent: 4230862 (1980-10-01), Suarez et al.
patent: 4418068 (1983-11-01), Jones
patent: 4614807 (1986-09-01), Flaugh
patent: 4623660 (1986-11-01), Richardson
patent: 4855305 (1989-08-01), Cohen
patent: 4943572 (1990-07-01), von Angerer
patent: 4997845 (1991-03-01), Flaugh
Blask, D. E., et al., J. Neural. Transm. [Suppl], 21: 433-449 (1986).
Blask, D. E., et al., Neuroendocrinol. Lett., 9, No. 2: 63-731 (1987).
Abram, W. P. et al., Br. J. Cancer, 57: 604-607 (1988).

Affiliated with

Also associated with

Rating

Melatonin derivatives and combinations with antiestrogen compoun does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Melatonin derivatives and combinations with antiestrogen compoun, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melatonin derivatives and combinations with antiestrogen compoun will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1351914